Rocuronium: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
''See [[critical care quick reference]] for drug doses by weight.'' | |||
==General== | ==General== | ||
*Type: Neuromuscular blocker, Non-Depolarizing, Fast Onset, Intermediate Lasting | *Type: Neuromuscular blocker, Non-Depolarizing, Fast Onset, Intermediate Lasting | ||
| Line 5: | Line 6: | ||
==Adult Dosing== | ==Adult Dosing== | ||
RSI | ===[[RSI]]=== | ||
*0.6 to 1.2 mg/kg IV (actual body weight) | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
RSI | ''See [[critical care quick reference]] for drug doses by weight.'' | ||
===[[RSI]]=== | |||
*0.6 to 1.2 mg/kg IV (actual body weight) | |||
==Special Populations== | ==Special Populations== | ||
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: C | *[[Drug Ratings in Pregnancy|Pregnancy Rating]]: C | ||
Revision as of 03:09, 24 February 2015
See critical care quick reference for drug doses by weight.
General
- Type: Neuromuscular blocker, Non-Depolarizing, Fast Onset, Intermediate Lasting
- Dosage Forms: IV
- Common Trade Names: Zemuron
Adult Dosing
RSI
- 0.6 to 1.2 mg/kg IV (actual body weight)
Pediatric Dosing
See critical care quick reference for drug doses by weight.
RSI
- 0.6 to 1.2 mg/kg IV (actual body weight)
Special Populations
- Pregnancy Rating: C
- Lactation: Infant risk cannot be ruled out
- Renal Dosing (half life approximately 1 hour longer if renal transplant patient)
- Adult
- Pediatric
- Hepatic Dosing (half life approximately 3 hours longer with liver dysfunction)
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Anaphylaxis
Common
Cardiovascular: HTN (0.1% to 2%). Hypotension (0.1% to 2%). Tachycardia (1% to 5.3%) Dermatologic: Pain at injection site Respiratory: Increased pulmonary vascular resistance (24%)
Pharmacology
- Half-life: Variable by age, but anywhere from 30 minutes to 2 hours.
- Metabolism: Metabolite is 17-desacetyl-rocuronium
- Excretion: Primary route is fecal. Renal also.
- Mechanism of Action: Non-depolarizing neuromuscular blocking agent. Intermediate duration with dose dependant rapid to intermediate onset. Competes for cholinergic receptors at the motor end-plate. Acetylcholinesterase inhibitors like those found in organophosphates antagonize this action
See Also
Sources
Micromedex